Application of oligonucleotide activation to restriction endonuclease NarI

Restriction endonuclease NarI cleaves DNA using a two-site mechanism, placing it in the Type IIe class of restriction endonucleases. Although these enzymes have very useful recognition sequences, the two-site mechanism limits the practical application. Site preferences often cause incomplete substra...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:BioTechniques. - 1993. - 22(1997), 6 vom: 15. Juni, Seite 1166-8
1. Verfasser: Senesac, J H (VerfasserIn)
Weitere Verfasser: Romanin, J K
Format: Aufsatz
Sprache:English
Veröffentlicht: 1997
Zugriff auf das übergeordnete Werk:BioTechniques
Schlagworte:Journal Article DNA, Viral Oligodeoxyribonucleotides Deoxyribonucleases, Type II Site-Specific EC 3.1.21.4 GGCGCC-specific type II deoxyribonucleases
LEADER 01000caa a22002652 4500
001 NLM091430763
003 DE-627
005 20250131052941.0
007 tu
008 231222s1997 xx ||||| 00| ||eng c
028 5 2 |a pubmed25n0305.xml 
035 |a (DE-627)NLM091430763 
035 |a (NLM)9187772 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Senesac, J H  |e verfasserin  |4 aut 
245 1 0 |a Application of oligonucleotide activation to restriction endonuclease NarI 
264 1 |c 1997 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 31.07.1997 
500 |a Date Revised 28.09.2018 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Restriction endonuclease NarI cleaves DNA using a two-site mechanism, placing it in the Type IIe class of restriction endonucleases. Although these enzymes have very useful recognition sequences, the two-site mechanism limits the practical application. Site preferences often cause incomplete substrate digestion. Oligonucleotide activation of NarI eliminates incomplete digestions, making it possible to use NarI restriction sites in many common molecular biology techniques. A modified oligonucleotide was chosen for optimal activation of restriction endonuclease NarI. This oligonucleotide was demonstrated to allow complete digestion in many commonly used substrates 
650 4 |a Journal Article 
650 7 |a DNA, Viral  |2 NLM 
650 7 |a Oligodeoxyribonucleotides  |2 NLM 
650 7 |a Deoxyribonucleases, Type II Site-Specific  |2 NLM 
650 7 |a EC 3.1.21.4  |2 NLM 
650 7 |a GGCGCC-specific type II deoxyribonucleases  |2 NLM 
650 7 |a EC 3.1.21.4  |2 NLM 
700 1 |a Romanin, J K  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t BioTechniques  |d 1993  |g 22(1997), 6 vom: 15. Juni, Seite 1166-8  |w (DE-627)NLM012627046  |x 0736-6205  |7 nnns 
773 1 8 |g volume:22  |g year:1997  |g number:6  |g day:15  |g month:06  |g pages:1166-8 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_21 
912 |a GBV_ILN_22 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_60 
912 |a GBV_ILN_62 
912 |a GBV_ILN_65 
912 |a GBV_ILN_70 
912 |a GBV_ILN_99 
912 |a GBV_ILN_121 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_350 
912 |a GBV_ILN_618 
912 |a GBV_ILN_640 
912 |a GBV_ILN_754 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2002 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2007 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2009 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2012 
912 |a GBV_ILN_2015 
912 |a GBV_ILN_2018 
912 |a GBV_ILN_2023 
912 |a GBV_ILN_2035 
912 |a GBV_ILN_2040 
912 |a GBV_ILN_2060 
912 |a GBV_ILN_2099 
912 |a GBV_ILN_2105 
912 |a GBV_ILN_2121 
912 |a GBV_ILN_2470 
951 |a AR 
952 |d 22  |j 1997  |e 6  |b 15  |c 06  |h 1166-8